Accelerated Fractionated Compared to Conventional Fractionated Salvage Radiation Therapy Improves Outcomes in Salvage Chemotherapy Refractory Diffuse Large B-Cell Lymphoma

被引：1
|
作者：
Coutu, B. [1 ]
Kallam, A. [1 ]
Lunning, M. [1 ]
Bociek, G. [1 ]
Bierman, P. [1 ]
Vose, J. [1 ]
Armitage, J. [1 ]
Enke, C. A. [1 ]
机构：
[1] Univ Nebraska Med Ctr, Omaha, NE USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2019.06.371
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1291
引用
收藏
页码：S249 / S250
页数：2
相关论文
共 50 条
  • [21] Salvage chemotherapy and autologous hematopoietic cell transplant in primary refractory diffuse large B-cell lymphoma: progress or better patient selection?
    Rosko, Ashley
    Lazarus, Hillard M.
    LEUKEMIA & LYMPHOMA, 2012, 53 (05) : 756 - 757
  • [22] Challenges in Administering Salvage Therapy and Outcomes of Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients: A LMIC Real-World Study
    Charanpreet Singh
    Aditya Jandial
    Arihant Jain
    Deepesh Lad
    Alka Khadwal
    Rajender Basher
    Amanjit Bal
    Pankaj Malhotra
    Gaurav Prakash
    Indian Journal of Hematology and Blood Transfusion, 2024, 40 : 231 - 236
  • [23] Challenges in Administering Salvage Therapy and Outcomes of Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients: A LMIC Real-World Study
    Singh, Charanpreet
    Jandial, Aditya
    Jain, Arihant
    Lad, Deepesh
    Khadwal, Alka
    Basher, Rajender
    Bal, Amanjit
    Malhotra, Pankaj
    Prakash, Gaurav
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024, 40 (02) : 231 - 236
  • [24] Outcomes of salvage chemotherapy and autologous stem cell transplantation for relapsed or refractory primary mediastinal large B cell lymphoma are not inferior to bulky diffuse large B cell lymphoma
    Kuruvilla, J
    Nagy, T
    Pintilie, M
    Keating, A
    Crump, M
    ANNALS OF ONCOLOGY, 2005, 16 : 100 - 100
  • [25] Gemcitabine, oxaliplatin and dexamethasone (GemDOx) as salvage therapy for relapsed or refractory diffuse large B-cell lymphoma and peripheral T-cell lymphoma
    Shen, Qiu-Dan
    Wang, Li
    Zhu, Hua-Yuan
    Liang, Jin-Hua
    Xia, Yi
    Wu, Jia-Zhu
    Fan, Lei
    Li, Jian-Yong
    Xu, Wei
    JOURNAL OF CANCER, 2021, 12 (01): : 163 - 169
  • [26] The Role of Radiation Therapy in Refractory or Relapsing Diffuse Large B-Cell Lymphoma
    Grignano, E.
    Laurent, J.
    Deau-Fisher, B.
    Burroni, B.
    Bouscary, D.
    Kirova, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E251 - E251
  • [27] Efficacy of conventional second-line salvage therapy in patients who have progressive disease after first-line salvage therapy with relapsed or refractory diffuse large B-cell lymphoma
    Kodaira, M.
    Yokoyama, M.
    Oooka, M.
    Asai, H.
    Ueda, K.
    Yamada, S.
    Myojo, T.
    Mishima, Y.
    Sakajiri, S.
    Takeuchi, K.
    Sakajiri, S.
    Takeuchi, K.
    Saotome, T.
    Terui, Y.
    Takahashi, S.
    Hatake, K.
    ANNALS OF ONCOLOGY, 2008, 19 : 219 - 219
  • [28] SALVAGE THERAPY FOR DIFFUSE LARGE-CELL LYMPHOMA
    CHABNER, BA
    BLOOD, 1990, 76 (07) : 1267 - 1268
  • [29] DexaBEAM plus Rituximab as second salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma with response failure to platinum-based first salvage regimen
    Mikesch, J-H
    Demant, A.
    Kuhlmann, M.
    Krug, U.
    Schmidt, E.
    Thoennissen, G. B.
    Koehler, G.
    Wessling, J.
    Mesters, R. M.
    Mueller-Tidow, C.
    Berdel, W. E.
    Thoennissen, N. H.
    ONKOLOGIE, 2013, 36 : 142 - 142
  • [30] Dual epigenetic agents plus rituximab-gemcitabine-oxaliplatin as salvage treatment in relapsed/refractory diffuse large B-cell lymphoma patients failure of salvage chemotherapy
    Qu, Changju
    Ping, Nana
    Kong, Danqing
    Liu, Aining
    Liu, Hailing
    Xu, Ting
    Xia, Fan
    Wu, Depei
    Jin, Zhengming
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (05) : 914 - 921
12345